Corvista System News Today

BETHESDA, Md.--(BUSINESS WIRE)--Apr 7, 2024--

WASHINGTON--(BUSINESS WIRE)--Nov 12, 2023--

WASHINGTON, November 12, 2023--CorVista Health, Inc., a leading digital health company dedicated to improving cardiovascular disease diagnosis, is pleased to announce the presentation of Machine Learning to Detect Pulmonary Hypertension data at AHA.

Recent developments of interest in cardiovascular medicine

WASHINGTON, August 09, 2023--CorVista Health, Inc, a leading digital health company dedicated to improving cardiovascular disease diagnosis, is pleased to announce the election of Dr. Tim Attebery to its Board of Directors.

FinancialContent fully hosted finance channel

CorVista Health Appoints Charles R. Bridges as Chief Scientific Officer - read this article along with other careers information, tips and advice on BioSpace

WASHINGTON--(BUSINESS WIRE)--Jan 18, 2022--

CARY — CorVista Health, Inc., which is jointly based in Cary and Toronto, Ontario, has closed a $65 million Series C round and plans to deploy the funds to fuel the development and commercialization of its non-invasive diagnostic system to assess for heart disease, bringing the total amount raised to nearly $100 million, said the company in a statement last month. The company, which until December, was known as Analytics 4 Life, reported the sale of nearly 9 million shares of Series A Preferr...

CorVista Health, a Toronto-based digital health company dedicated to improving cardiovascular disease diagnosis raises $65M in Series C funding.